Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
BioViotica
Bafilomycin B1
60
CHF
CHF 60.00
In stock
BVT-0004-C100100 µgCHF 60.00
BVT-0004-M0011 mgCHF 110.00
BVT-0004-M0055 mgCHF 430.00
| Product Details | |
|---|---|
| Synonyms | Setamycin; BRN4640118 |
| Product Type | Chemical |
| Properties | |
| Formula |
C44H65NO13 |
| MW | 815.9 |
| CAS | 88899-56-3 |
| RTECS | LX8920000 |
| Source/Host Chemicals | Isolated from Streptomyces hygroscopicus. |
| Purity Chemicals | ≥97% (HPLC) |
| Appearance | Yellow solid. |
| Solubility | Soluble in DMSO or acetone. Insoluble in water. Unstable in methanol. |
| Identity | Determined by 1H-NMR. |
| Declaration | Manufactured by BioViotica. |
| InChi Key | KFUFLYSBMNNJTF-APLCIVFZSA-N |
| Smiles | [H][C@@]1(OC(=O)\C(OC)=C\C(\C)=C\[C@@H](C)[C@@H](O)[C@@H](C)C\C(C)=C\C=C/[C@@H]1OC)[C@@H](C)[C@@H](O)[C@H](C)[C@@]1(O)C[C@@H](OC(=O)\C=C\C(=O)NC2=C(O)CCC2=O)[C@H](C)C(O1)C(C)C |
| Shipping and Handling | |
| Shipping | AMBIENT |
| Short Term Storage | +4°C |
| Long Term Storage | -20°C |
| Handling Advice | Protect from light when in solution. |
| Use/Stability |
Stable for at least 1 year after receipt when stored at -20°C. After reconstitution protect from light at -20°C. |
| Documents | |
| MSDS |
 Download PDF |
| Product Specification Sheet | |
| Datasheet |
Download PDF |
Description
- Macrolide antibiotic.
- Specific vacuolar-type H+-ATPase inhibitor.
- Inhibitor of autophagic degradation by rising lysosomal pH and thus inactivating the lysosomal acid hydrolases.
- Antitrypanosomal and antileishmanial compound.
- Phytotoxic.
- Influences the cell wall biosynthesis of Asp. niger.
Product References
- Metabolic products of microorganisms. 224. Bafilomycins, a new group of macrolide antibiotics. Production, isolation, chemical structure and biological activity: G. Werner, et al.; J. Antibiot. (Tokyo) 37, 110 (1984)
- Inhibitory effect of modified bafilomycins and concanamycins on P- and V-type adenosinetriphosphatases: S. Drose, et al.; Biochemistry 32, 3902 (1993)
- Bafilomycins and concanamycins as inhibitors of V-ATPases and P-ATPases: S. Drose and K. Altendorf; J. Exp. Biol. 200, 1 (1997)
- Biosynthetic investigations of the V-type ATPase inhibitors bafilomycin A1, B1 and concanamycin A: T. Schuhmann and S. Grond; J. Antibiot. (Tokyo) 57, 655 (2004)
- Autophagy, bafilomycin and cell death: the "a-B-cs" of plecomacrolide-induced neuroprotection: J.J. Shacka, et al.; Autophagy 2, 228 (2006)
- Bafilomycins produced in culture by Streptomyces spp. isolated from marine habitats are potent inhibitors of autophagy: G. Carr, et al.; Journal of Nat. Prod. 73, 422 (2010)
- Low-dose bafilomycin attenuates neuronal cell death associated with autophagy-lysosome pathway dysfunction: V. N. Pivtoraiko; J. Neurochem. 114, 1193 (2010)
- Vacuolar H(+)-ATPase plays a keyrole in cell wall biosynthesis of Aspergillus niger: D. Schachtschabel, et al.; Fungalgenet. Biol. 49, 284 (2012)
- Characterization of the bafilomycin biosynthetic gene cluster from Streptomyces lohii: W. Zhang, et al.; ChemBioChem 14, 301 (2013)
- Isolation and characterization of phytotoxic compounds produced by Streptomyces sp. AMC 23 from red mangrove(rhizophora mangle): E. Crevelin, et al.; Appl. Biochem. Biotechnol. 171, 1602 (2013)
- High-throughput screening platform for natural product-based drug discovery against 3 neglected tropical diseases: human African trypanosomiasis, leishmaniasis, and chagas disease: F. Annang, et al.; J. Biomol. Screen. 20, 82 (2015)
Related Products
